That’s what saved Bill Gantz’s pharmaceutical giant Baxter Corp.
Back in 1992, Gantz raised $42 million to develop a “perfect” drug that could cure lung infections in patients with cystic fibrosis. The hitch: In clinical trials, it didn’t work.
Luckily (well, it was more than luck), the company had identified a second promising drug and licensed it before the failed trial. With Plan B in his back pocket, Gantz saved his company and sold it to Chiron Novartis for $720 million.
— Adapted from How They Did It, Robert Jordan, RedFlash Press.
Like what you've read? ...Republish it and share great business tips!
Attention: Readers, Publishers, Editors, Bloggers, Media, Webmasters and more...
We believe great content should be read and passed around. After all, knowledge IS power. And good business can become great with the right information at their fingertips. If you'd like to share any of the insightful articles on BusinessManagementDaily.com, you may republish or syndicate it without charge.
The only thing we ask is that you keep the article exactly as it was written and formatted. You also need to include an attribution statement and link to the article.
" This information is proudly provided by Business Management Daily.com: http://www.businessmanagementdaily.com/30516/always-have-plan-b "